Evidence and Guidance Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes and weight management
Contact your provider to report the error
Currently, Medicare plans typically dont cover Wegovy for weight loss, but they may cover it for cardiovascular risk reduction
In some integrated care systems, GPs with enhanced diabetes training may initiate GLP-1 therapy directly, supported by local prescribing protocols
When there were also setbacks in pharmaceutical research, for example when diabetes treatment was switched from injections to pills, many companies walked away from the fight against obesity
If you are into Gotu Kola we have some more info at Centella Asiatica Extract and its other biologically active components Madecassoside, Asiaticoside and Asiatic Acid